Families face battle with GSK over dangerous diabetes drug...

Thousands of families in the UK could be deprived of compensation for the death or harm of a relative caused by the diabetes drug Avandia, even though the British maker has agreed to pay billions of dollars to settle similar claims in the US.

The licence for Avandia was revoked in Europe, in September 2010, because of evidence that it could cause heart failure and heart attacks. The drug can still be prescribed in the US, but not to patients at risk of heart problems.

A scientist with the Food and Drug Administration estimated that Avandia could have been responsible for 100,000 heart attacks in the US.

The manufacturer, GlaxoSmithKline, has admitted concealing data about the damaging side-effects of the drug, and there is evidence of the drug's harmful effects. But, despite this, GSK is not prepared to settle claims in the UK without a court fight. Full story...

Related posts:

1. GlaxoSmithKline whistleblower speaks out about bribery of doctors...
2. Drug giant GlaxoSmithKline to pay $3billion in US drug fraud scandal...
3. Dr. Drew allegedly paid by GlaxoSmithKline to hawk more than just advice...
4. Drug giants fined $11bn for criminal wrongdoing, but fines are not enough...
5. Big Pharma routinely suppresses data from clinical trials...
6. Allergy fears halt distribution of GlaxoSmithKline swine flu vaccine in Canada...
7. How Big Pharma dopes and dupes...